Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Argus Health
Mallinckrodt
US Department of Justice
Deloitte
QuintilesIMS
Johnson and Johnson
McKinsey
Daiichi Sankyo

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019851

« Back to Dashboard

NDA 019851 describes LOTENSIN, which is a drug marketed by Us Pharms Holdings I and is included in two NDAs. It is available from one supplier. Additional details are available on the LOTENSIN profile page.

The generic ingredient in LOTENSIN is benazepril hydrochloride; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the benazepril hydrochloride; hydrochlorothiazide profile page.
Summary for 019851
Tradename:LOTENSIN
Applicant:Us Pharms Holdings I
Ingredient:benazepril hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 019851
Suppliers and Packaging for NDA: 019851
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LOTENSIN benazepril hydrochloride TABLET;ORAL 019851 NDA Validus Pharmaceuticals LLC 30698-448 N 30698-448-01
LOTENSIN benazepril hydrochloride TABLET;ORAL 019851 NDA Validus Pharmaceuticals LLC 30698-449 N 30698-449-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Jun 25, 1991TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Jun 25, 1991TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Jun 25, 1991TE:ABRLD:Yes

Expired US Patents for NDA 019851

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-003 Jun 25, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Us Pharms Holdings I LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-004 Jun 25, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Us Pharms Holdings I LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-001 Jun 25, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Us Pharms Holdings I LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-002 Jun 25, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKesson
Moodys
Argus Health
AstraZeneca
Harvard Business School
Merck
Baxter
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.